Login
$CME
$319.13 +$1.16 (0.36%) Live

$CME 8-K SEC Filings

Filed On Filing
21 Oct 2026 8-K: Results of Operations and Financial Condition

CHICAGO, October 21, 2026 - CME Group Inc. (NASDAQ: CME) today reported financial results for the third quarter of 2026.

25 Sep 2026 8-K: Amendments to Articles/Bylaws; Change in Fiscal Year

CME Group Inc., a Delaware corporation (the “Corporation”), does hereby certify that, at a duly convened meeting of the board of directors of the Corporation (the “Board of Directors”) on May 6, 2026, the Board of Directors duly adopted ...

09 Sep 2026 8-K: Departure/Election of Directors or Officers; Compensation

CHICAGO, September 9, 2026 – CME Group, the world’s leading derivatives marketplace, today announced senior leadership appointments in its finance and legal divisions.

11 Aug 2026 8-K: Regulation FD Disclosure

On August 11, 2026, CME Group Inc. communicated pricing changes to its clients via Special Executive Report No. 9799. A copy of this notice has been posted to the Company’s website.

22 Jul 2026 8-K: Results of Operations and Financial Condition

CHICAGO, July 22, 2026 - CME Group Inc. (NASDAQ: CME) today reported financial results for the second quarter of 2026.

17 Jun 2026 8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure

This TRANSITION AND EXECUTIVE CHAIRMAN AGREEMENT (this “Agreement”) is entered into on June 16, 2026 by and between CME Group Inc., a Delaware Corporation (together with its subsidiaries and affiliates, the “Employer” or “CME”), and Terr...

10 Jun 2026 8-K: Submission of Matters to a Vote of Security Holders

On May 14, 2026, CME Group Inc. (the “Company”) held its 2026 Annual Meeting of Shareholders (the “Annual Meeting”). Due to lack of quorum among the Class B-1, Class B-2 and Class B-3 shareholders, the proposals presented under Items 4 t...

19 May 2026 8-K: Submission of Matters to a Vote of Security Holders

CME Group Inc. (the “Company”) held its 2026 Annual Meeting of Shareholders on May 14, 2026 (the “Annual Meeting”). At the close of business on March 16, 2026, the record date of the Annual Meeting, the Company had 362,808,081 shares of ...

27 Apr 2026 8-K: Entry into a Material Definitive Agreement

EXHIBIT 10.1 AMENDMENT NO. 11 TO CREDIT AGREEMENT (2026 FACILITY RENEWAL) This AMENDMENT NO. 11 TO CREDIT AGREEMENT (this “Amendment”) dated as of April 22, 2026, is among CHICAGO MERCANTILE EXCHANGE INC., a Delaware corporation (the “Co...

22 Apr 2026 8-K: Results of Operations and Financial Condition

CME Group Inc. Reports Record Revenue, Adjusted Operating Income, Adjusted Net Income and Adjusted Earnings Per Share for Q1 2026

04 Feb 2026 8-K: Results of Operations and Financial Condition

CME Group Inc. Reports Fourth Consecutive Year of Record Annual Revenue, Adjusted Operating Income, Adjusted Net Income and Adjusted Earnings Per Share for 2025

02 Feb 2026 8-K: Regulation FD Disclosure

On February 2, 2026, CME Group Inc. communicated pricing changes to its clients via Special Executive Report 9676. A copy of this notice has been posted to the Company’s website.

22 Oct 2025 8-K: Results of Operations and Financial Condition

CHICAGO, October 22, 2025 - CME Group Inc. (NASDAQ: CME) today reported financial results for the third quarter of 2025.

11 Sep 2025 8-K: Departure/Election of Directors or Officers; Compensation

Departure of Directors or Certain Officers; Election of Directors; Appointmentof Certain Officers; Compensatory Arrangements of Certain Officers.

25 Jul 2025 8-K: Other Events

On July 25, 2025, a jury returned a unanimous verdict in favor of CME Group Inc. (“CME Group”) and the Board of Trade of the City of Chicago, Inc. (“CBOT”) in the putative class action that was filed on January 15, 2014 in the Circuit Co...

23 Jul 2025 8-K: Results of Operations and Financial Condition

CME Group Inc. Reports All-Time Record Revenue, Adjusted Operating Income, Adjusted Net Income and Adjusted Earnings Per Share for Q2 2025

09 May 2025 8-K: Submission of Matters to a Vote of Security Holders

CME Group Inc. (the “Company”) held its 2025 Annual Meeting of Shareholders on May 8, 2025 (the “Annual Meeting”).

25 Apr 2025 8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation

EXHIBIT 10.1 202207671_6 CUSIP Numbers: Deal: 12572RAZ6 MC Revolver: 12572RBA0 USD Revolver: 12572RBB8 $2,250,000,000 AMENDED AND RESTATED CREDIT AGREEMENT Dated as of April 23, 2025 among CME GROUP INC., as Borrower, THE LENDERS PARTY H...

23 Apr 2025 8-K: Results of Operations and Financial Condition

CME Group Inc. Reports All-Time Record Revenue, Adjusted Operating Income, Adjusted Net Income and Adjusted Earnings Per Share for Q1 2025

14 Apr 2025 8-K: Regulation FD Disclosure

New York, NY, April 14, 2025—S&P Global and CME Group today announced the signing of a definitive agreement to sell OSTTRA, a leading provider of post-trade solutions for the global OTC market, to investment funds managed by KKR, a leadi...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support